ArticleBMC cancer2026

Atezolizumab versus pembrolizumab in the treatment of advanced triple-negative breast cancer: a Bayesian network meta-analysis of ITT and PD-L1 positive populations.

I Gede Wikania Wira Wiguna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.